Frailty and checkpoint inhibitor toxicity in older patients with melanoma

BACKGROUND: Immune checkpoint inhibitors (ICIs) can cause immune‐related adverse events (irAEs) that range from mild to life‐threatening. Age itself does not seem to be a predictor for the occurrence of irAEs. It is unknown whether frailty plays a role in the occurrence of irAEs. Therefore, the auth...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruijnen, Cheryl P., Koldenhof, José J., Verheijden, Rik J., van den Bos, Frederiek, Emmelot‐Vonk, Mariëlle H., Witteveen, Petronella O., Suijkerbuijk, Karijn P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325486/
https://www.ncbi.nlm.nih.gov/pubmed/35439334
http://dx.doi.org/10.1002/cncr.34230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325486/
https://www.ncbi.nlm.nih.gov/pubmed/35439334
http://dx.doi.org/10.1002/cncr.34230

Ejemplares similares